Civic AI
Civic AI
Procurement intelligence
SAM.gov140D0426Q0826
Open

Element Biosciences AVITI¿ 24 sequencing and spati

Response deadline
Aug 27, 2026
Due in 16 days
Date posted
Aug 11, 2026

Description

The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF).

Classifications

Documents (2)

  • B08_SOL__Attachment_1_Statement_of_Need.docx
    .docx43 KB
    Download
  • B10_PFP__Notice_of_Intent_to_Sole_Source.docx
    .docx99 KB
    Download

Contacts

Similar contracts

Explore more